pichia.com

Products Made in the Pichia Yeast Protein Expression System

Products Made in Pichia

Product: Medway (recombinant human serum albumin, or rHSA)
Company: Mitsubishi Tanabe Pharma Corporation, Osaka, Japan
Indication: Blood expander
Status: On the market in Japan
Website: http://bipha.co.jp/english/index.html


Product: Hepatitis B vaccine
Company: Shantha Biotechnics Ltd., India
Indication: Hepatitis B
Status: On the market in India
Website: http://www.shanthabiotech.com/shanvac_b.htm


Product: Interferon-alpha
Company: Shantha Biotechnics Ltd., India
Indication: Hepatitis C/Cancer
Status: On the market in India
Website: http://www.shanthabiotech.com/shanferon.htm


Product: DX-88
Company: Dyax Corporation, Cambridge, Mass.
Indication: hereditary angioedema (HAE), a debilitating condition characterized by acute attacks of inflammation.
Status: BLA submitted
Website: http://www.dyax.com/clinical/hereditaryang.html


Product: Recombinant Human Insulin
Company: Biocon, India
Indication: Diabetes, all types
Status: On the market in India
Website: http://www.biocon.com/


Product: Recombinant collagen
Company: Fibrogen Inc., South San Francisco, Calif.
Indication: Medical research reagents and dermal filler
Status: On the market
Website: http://www.fibrogen.com/


Product: AquaVacTM IPN salmon vaccines for infectious pancreatic necrosis
Company: Schering Plough Animal Health
Indication: Vaccines for infectious pancreatic necrosis in salmon
Status: Sold under a limited approval in Chile; approved for sales in Norway
Website: http://www.spaquaculture.com/


Product: Recombinant allergens (house dust mite, cat, mouse and cockroach)
Company: INDOOR Biotechnologies, Charlottesville, Va.
Indication: Research use
Status: On the market
Website: http://www.inbio.com/


Product: Recombinant Phytase
Company: Phytex, LLC.
Indication: Animal feed additive
Status: On the market
Website: http://www.optiphos.net/


Product: Superior Stock Nitrate ReductaseTM
Company: The Nitrate Elimination Co., Lake Linden, Mich.
Indication: Enzyme-based products for water testing and water treatment
Status: On the market
Website: http://www.nitrate.com/


Product: Recombinant endotoxin neutralizing protein
Company: Associates of Cape Cod, Inc., East Falmouth, Mass.
Indication: Products for detecting and quantifying gram-negative bacterial endotoxins (research use)
Status: On the market
Website: http://www.acciusa.com/


Product: Recombinant Human Cystatin C
Company: Scipac PLC, Kent, U.K.
Indication: Research reagent
Status: On the market in Europe
Website: http://www.scipac.com/


Product: Botulism vaccine
Company: USAMRIID/DynPort
Indication: Botulism vaccine product
Status: Phase I (U.S.)
Website: http://www.csc.com/dvc


Product: Anti-thrombolytic
Company: ThromboGenics Ltd.
Indication: Thrombosis Tx
Status: Phase II
Website: http://www.thrombogenics.com/


Licensing Information

For Pichia licensing, contact:

David Bramhill, Ph.D., Director,
Gene eXpression Technologies Program
or Andrea Isner, Assistant to
David Bramhill, Ph.D.
Research Corporation Technologies
5210 East Williams Circle, Suite 240
Tucson, AZ 85711-4410
Telephone: (520) 748-4443
Fax: (520) 748-0025
E-mail Dr. Bramhill
E-mail Andrea Isner
Web: http://www.rctech.com

For Pichia kit purchases, technical and custom services:

Invitrogen Corp.
Telephone: (800) 955-6288
Fax: (760) 602-6500
Web: http://www.invitrogen.com


Research Corporation Technologies logo
General Information:
Research Corp. Technologies
5210 East Williams Circle, Suite 240
Tucson, AZ 85711-4410 USA
Telephone: (520) 748-4400
Fax: (520) 748-0025
E-mail: pichia@rctech.com
Web: http://www.rctech.com